comparemela.com

Latest Breaking News On - Wincal biopharm wincalbio - Page 1 : comparemela.com

PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024

DAEJEON, South Korea, April 23, 2024 /PRNewswire/ PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company

South-san-francisco
California
United-states
South-korea
Daejeon
Taejon-gwangyoksi
Thailand
Venice-chiueh
Wincal-biopharm-wincalbio
Taeweon-lee
Seattle-convention-center
Pharmabcine-inc

PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmo

PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmo
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Daejeon
Taejon-gwangyoksi
South-korea
United-states
South-san-francisco
California
Venice-chiueh
Taeweon-lee
Wincal-biopharm-wincalbio
Association-for-research
Seattle-convention-center
Wincal-biopharm-inc
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.